Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CTAGE family member 10, pseudogene (CTAGE10P) is a processed pseudogene located on chromosome 13 (13q14.2)[3][2][7]. Pseudogenes like CTAGE10P are regions of DNA similar to known genes but rendered non-functional due to mutations (such as frameshifts or premature stop codons) and do not encode functional proteins[6]. CTAGE10P is not known to have a protein product, and there is no direct evidence linking it to specific biological functions, diseases, or therapeutic targeting. Processed pseudogenes can sometimes influence gene expression through regulatory RNAs or genetic recombination, but no such roles are established for CTAGE10P specifically[6][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CTAGE family member 10, pseudogene (CTAGE10P).